ACTRN12613000421730
已完成
未知
A Multi-Center, Single Arm Pilot Study to assess improvement in Pain and Function in Patients with medial compartment Knee OA treated with the KineSpring PEEK System
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Medial Knee Osteoarthritis
- 发起方
- Moximed, Inc.
- 入组人数
- 9
- 状态
- 已完成
- 最后更新
- 4年前
概览
简要总结
The purpose of this study was to evaluate the improvement in pain and function following implantation of the KineSpring PEEK System in patients with osteoarthritis of the medial compartment of the knee. The PEEK clinical study primary effectiveness endpoint of decrease in pain and function measured by WOMAC at 6 months compared to baseline was met. Overall, seven subjects (7/9, 77.8%) experienced improvement in both WOMAC pain and function scores. In the first 6 months, there were no device-related adverse events. Therefore, the primary safety endpoint was also met.
研究者
入排标准
入选标准
- •1\. Documented diagnosis of primary OA of the target knee made at least 6 months prior to screening, 2\.Documented radiographic evidence of medial OA as demonstrated by a Kellgren\-Lawrence grade of \>\=2 (scale 0\-4\) as assessed by the investigator, 3\.Has continued target knee OA pain despite 6 months of conservative treatment prior to surgery, 4\. Has pain in the target knee as demonstrated by a minimum score of 40 (scale 0\-100\) on the KOOS/WOMAC pain domain questions, 5\. Aged minimum 25 years, 6\. Knee flexion \>\=90 degrees to \<\=140 degrees, 7\. Weight \<300 lbs (136\.4kg)
排除标准
- •1\. Active infection, sepsis, osteomyelitis or history of septic arthritis in any joint, 2\. Rheumatoid arthritis or other forms of inflammatory joint disease, 3\. Significant OA in lateral or patello\-femoral compartment as measured by Kellgren Lawrence grade of 2 or 3, respectively, 4\. Significant OA in the contralateral knee likely to necessitate surgical intervention within 12 months of enrollment, 5\. Previous joint modifying surgery in the target knee within 12 months prior to planned surgery date such as ligament reconstruction or meniscus repair, cartilage transplantation, and microfracture \- a. Arthroscopic surgeries for joint lavage, menisectomy, chondral debridement, and loose body removal are excluded if within 3 months prior to planned surgery date, 6\. Previous osteotomy or failed knee joint replacement in the target knee, 7\. Tibial\-femoral varus or varus alignment \>10 degrees, 8\. Hyperextension \>5degrees, 9\. Flexion deformity greater than 10 degrees, 10\. Ligamentous laxity, or meniscal instability as assessed by the investigator, 11\. Uncontrolled diabetes mellitus, 12\. Moderate to severe osteoporosis, 13\. Concomitant immunosuppressive therapy, 14\. Metabolic disorders which may impair bone formation, 15\. Osteomalacia, 16\. Distant foci of infections which may spread to the implant site, 17\. Rapid joint destruction, marked bone loss or bone resorption apparent on x\-ray, 18\. Vascular insufficiency, muscular atrophy, neuromuscular disease, 19\. Any significant medical condition or other factor that the Investigator feels would interfere with study participation, 20\. Pregnancy or lactation, 21\. Prisoners
结局指标
主要结局
未指定
相似试验
已完成
4 期
Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or RebifRelapsing-remitting Multiple SclerosisNCT00317941Bayer220
已完成
不适用
Rehabilitative Effect of the Use of a Gait Exoskeleton in Patients With Neuromuscular Disease or Cerebral PalsyNeuromuscular DiseasesCerebral PalsySMA IINCT04813601MarsiBionics10
已完成
4 期
An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal DisordersSpinal DisordersNCT01811238Mundipharma Korea Ltd240
进行中（未招募）
2 期
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA PainOsteoarthritis, KneeNCT04809376Paradigm Biopharmaceuticals USA (INC)602
已完成
不适用
A Study of BiZact™ on Adults Undergoing TonsillectomyTonsillectomyNCT02876575Medtronic - MITG48